Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition
Sponsor: Celestra Health Systems
Summary
To measure the effectiveness of a Remote Patient Monitoring solution based on the use of a smart insole wearable device (and associated smart phone app), for monitoring MS patients' condition on a day-to-day basis. The main focus is the objective measurement of gait, given that 75% of people with MS display clinically significant gait impairments. Initial gait lab "gold standard" data indicate that the Artificial Intelligence (AI)-based digital biomarker will prove to be highly effective at detecting changes in the MS patient's condition.
Official title: A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Disease Condition Through Home Monitoring of MS Patients
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
90
Start Date
2023-07-01
Completion Date
2026-12-31
Last Updated
2026-03-20
Healthy Volunteers
Not specified
Conditions
Locations (3)
Brigham and Women's Hospital
Boston, Massachusetts, United States
The Ottawa Hospital
Ottawa, Ontario, Canada
The Royal London Hospital
London, United Kingdom